Healthcare Industry News: blood glucose
News Release - July 31, 2007
FDA Clears New GlucosePilot(TM) Blood Glucose Meter SystemCARLSBAD, CA--(Healthcare Sales & Marketing Network)--Jul 31, 2007 -- Aventir Biotech announced today that it has received 510(k) clearance for its GlucosePilot(TM) blood glucose Monitoring System. The GlucosePilot(TM) offers an easy-to-use, cost effective and convenient way for patients and hospitals to manage diabetes. Research has shown consistent glucose monitoring; helps improve the control of glucose levels in patients as well as lower the risk of long-term complications of diabetes. Source: Aventir Biotech
"Our mission for the GlucosePilot(TM) and GlucosePilot(TM) Test Strips is to deliver the highest quality glucose testing system while making it affordable for people to use around the world," stated Joy Lee, Chief Operating Officer of Aventir Biotech, LLC.
The GlucosePilot(TM) blood glucose Test System utilizes the latest in Biosensor Technology to make blood glucose testing faster, more reliable and easier to use than conventional colorimetric blood glucose testing techniques.
Aventir Biotech, LLC. is a FDA-registered company located in Carlsbad, CA specializing in the development and manufacturing of in-vitro diagnostic devices for the detection of drugs of abuse, fertility hormones, cancer markers, infectious diseases and glucose. Aventir proudly offers high-quality, cost-effective products for point-of-care needs worldwide.
Please visit www.aventirbio.com for additional information.
Source: Aventir Biotech
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.